Literature DB >> 23991657

The randomized registry trial--the next disruptive technology in clinical research?

Michael S Lauer1, Ralph B D'Agostino.   

Abstract

Mesh:

Year:  2013        PMID: 23991657     DOI: 10.1056/NEJMp1310102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  150 in total

1.  Overcoming underpowering: Trial simulations and a global rank end point to optimize clinical trials in children with heart disease.

Authors:  Kevin D Hill; H Scott Baldwin; David P Bichel; Alicia M Ellis; Eric M Graham; Christoph P Hornik; Jeffrey P Jacobs; Robert D B Jaquiss; Marshall L Jacobs; Prince J Kannankeril; Jennifer S Li; Rachel Torok; Joseph W Turek; Sean M O'Brien
Journal:  Am Heart J       Date:  2020-05-20       Impact factor: 4.749

2.  Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry.

Authors:  Robert W Yeh; Matthew J Czarny; Sharon-Lise T Normand; Dean J Kereiakes; David R Holmes; Ralph G Brindis; W Douglas Weaver; John S Rumsfeld; Matthew T Roe; Sunghee Kim; Priscilla Driscoll-Shempp; Laura Mauri
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-11-16

Review 3.  Widening the path and window of opportunity for FDA approval of non-vitamin K oral anticoagulant specific antidotes and reversal agents.

Authors:  Sunny Patel; Dylan Steen
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

4.  From Pharmacovigilance to Clinical Care Optimization.

Authors:  Leo Anthony Celi; Edward Moseley; Christopher Moses; Padhraig Ryan; Melek Somai; David Stone; Kai-Ou Tang
Journal:  Big Data       Date:  2014-09-01       Impact factor: 2.128

5.  Japan-Retinal Detachment Registry Report I: preoperative findings in eyes with primary retinal detachment.

Authors:  Taiji Sakamoto; Sumihiro Kawano; Ryo Kawasaki; Akito Hirakata; Hidetoshi Yamashita; Shuichi Yamamoto; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2019-11-23       Impact factor: 2.447

6.  [Colorectal liver metastasis: More chemotherapy, more surgery?].

Authors:  H Dralle
Journal:  Chirurg       Date:  2014-01       Impact factor: 0.955

7.  Registry-based trials: a potential model for cost savings?

Authors:  Brett R Anderson; Evelyn G Gotlieb; Kevin Hill; Kimberly E McHugh; Mark A Scheurer; Carlos M Mery; Glenn J Pelletier; Jonathan R Kaltman; Owen J White; Felicia L Trachtenberg; Danielle Hollenbeck-Pringle; Brian W McCrindle; Donna M Sylvester; Aaron W Eckhauser; Sara K Pasquali; Jeffery B Anderson; Marcus S Schamberger; Subhadra Shashidharan; Jeffrey P Jacobs; Marshall L Jacobs; Marko Boskovski; Jane W Newburger; Meena Nathan
Journal:  Cardiol Young       Date:  2020-05-08       Impact factor: 1.093

8.  Site selection for heart failure clinical trials in the USA.

Authors:  Matthew E Harinstein; Javed Butler; Stephen J Greene; Gregg C Fonarow; Norman L Stockbridge; Christopher M O'Connor; Marc A Pfeffer; Mandeep R Mehra; Scott D Solomon; Clyde W Yancy; Mona Fiuzat; Robert J Mentz; Sean P Collins; John J V McMurray; Muthiah Vaduganathan; Preston M Dunnmon; Giuseppe M C Rosano; Wilfried Dinh; Frank Misselwitz; Robert O Bonow; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

9.  Perspective: Limiting Dependence on Nonrandomized Studies and Improving Randomized Trials in Human Nutrition Research: Why and How.

Authors:  John F Trepanowski; John P A Ioannidis
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

10.  Decrease in antibiotic use, an added benefit of PCVs.

Authors:  Carlos G Grijalva
Journal:  Lancet Infect Dis       Date:  2013-11-26       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.